Seeking Advice on IRM: Hold or Sell Amid Price Decline & Borrowed Funds

I’m currently holding 592.165 shares of IRM entirely in my TFSA, with a book cost of $66,563.52 USD—averaging about $112.41 per share. Most of these shares were bought using an $80,000 CAD line of credit (variable rate at 6.20%) back in November 2024 when IRM was around $120 USD. Now that the stock has fallen to $87.94 USD, I’m in a dilemma.

IRM was still being rated as a solid long-term buy with potential to reach $130 again (which is why I never sold right away), but given the steep drop and the interest accumulating on my credit line, I’m questioning whether I should hang on or sell now to stop the bleeding.

What are your thoughts on:

* The likelihood of a rebound to previous high targets? * Risk management strategies when 100% of your TFSA is tied to one stock? * Balancing the cost of borrowing against the potential for recovery?

Any advice or alternative perspectives would be appreciated.

Note: I used ChatGPT to help me with the wording of this question in case anyone cares. My first attempt was just terrible so I figured a better worded question would get better responses. I also know I'm an idiot who threw everything into a single stock, I've been beating myself up about this for a while now so please don't add to it.